Fiche société
Upsher-Smith Laboratories
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Sumatriptan 10 mg Nasal SprayA safety and efficacy study of DFN-02 (Sumatriptan Nasal Spray 10 mg), being conducted at multiple centers in the United States. | Migraine | Phase 2 | À vérifier | United States | À vérifier |
| Sumatriptan 10 mg Nasal SprayA safety and efficacy study of DFN-02 (Sumatriptan Nasal Spray 10 mg), being conducted at multiple centers in the United States. | Migraine | Phase 2 | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Sumatriptan 10 mg Nasal Spray | Migraine | Phase 2 | NCT02856802 | An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg) | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||